ADH7
Basic information
Region (hg38): 4:99412261-99435510
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADH7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 31 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 8 | 1 |
Variants in ADH7
This is a list of pathogenic ClinVar variants found in the ADH7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-99413155-G-T | not specified | Uncertain significance (May 26, 2022) | ||
4-99415601-T-C | not specified | Uncertain significance (Dec 27, 2022) | ||
4-99419013-G-A | not specified | Uncertain significance (May 23, 2023) | ||
4-99419019-T-C | not specified | Uncertain significance (Apr 29, 2024) | ||
4-99419034-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
4-99419054-G-A | not specified • ADH7-related disorder | Uncertain significance (Aug 02, 2021) | ||
4-99419058-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
4-99419063-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
4-99419073-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
4-99419076-C-A | not specified | Uncertain significance (May 23, 2024) | ||
4-99419079-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
4-99419115-C-A | not specified | Uncertain significance (Feb 27, 2024) | ||
4-99420546-T-C | not specified | Likely benign (Feb 26, 2024) | ||
4-99420587-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
4-99420595-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
4-99420676-T-G | not specified | Uncertain significance (May 14, 2024) | ||
4-99420682-T-C | Benign (Dec 31, 2019) | |||
4-99420690-T-A | not specified | Uncertain significance (May 23, 2024) | ||
4-99420699-A-T | not specified | Uncertain significance (Dec 07, 2021) | ||
4-99420772-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
4-99427779-A-G | ADH7-related disorder | Uncertain significance (Jul 09, 2024) | ||
4-99427816-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
4-99427832-C-G | not specified | Uncertain significance (Oct 16, 2023) | ||
4-99427858-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
4-99427861-T-C | not specified | Uncertain significance (May 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADH7 | protein_coding | protein_coding | ENST00000476959 | 9 | 23477 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.51e-11 | 0.0295 | 125700 | 0 | 47 | 125747 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.613 | 245 | 219 | 1.12 | 0.0000110 | 2566 |
Missense in Polyphen | 89 | 74.546 | 1.1939 | 895 | ||
Synonymous | 0.630 | 70 | 77.0 | 0.909 | 0.00000395 | 781 |
Loss of Function | -0.263 | 16 | 14.9 | 1.07 | 6.20e-7 | 216 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000609 | 0.000608 |
Ashkenazi Jewish | 0.00120 | 0.00119 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000439 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000399 | 0.000392 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Could function in retinol oxidation for the synthesis of retinoic acid, a hormone important for cellular differentiation. Medium-chain (octanol) and aromatic (m-nitrobenzaldehyde) compounds are the best substrates. Ethanol is not a good substrate but at the high ethanol concentrations reached in the digestive tract, it plays a role in the ethanol oxidation and contributes to the first pass ethanol metabolism.;
- Pathway
- Retinol metabolism - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Cyclophosphamide Pathway, Pharmacodynamics;Ifosfamide Pathway, Pharmacodynamics;Fatty Acid Omega Oxidation;Nuclear Receptors Meta-Pathway;NRF2 pathway;Amino Acid metabolism;Phase I - Functionalization of compounds;Ethanol oxidation;Biological oxidations;Metabolism;Tyrosine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.267
Intolerance Scores
- loftool
- 0.972
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.38
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.155
- ghis
- 0.399
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.184
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adh7
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); taste/olfaction phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- retinoid metabolic process;ethanol catabolic process;ethanol oxidation;response to bacterium;fatty acid omega-oxidation;retinol metabolic process;retinoic acid metabolic process;response to ethanol;oxidation-reduction process;extracellular negative regulation of signal transduction
- Cellular component
- extracellular region;cytosol;plasma membrane
- Molecular function
- alcohol dehydrogenase (NAD) activity;alcohol dehydrogenase activity, zinc-dependent;aldehyde oxidase activity;retinol dehydrogenase activity;zinc ion binding;retinol binding;ethanol binding;receptor antagonist activity